Premium
Molecular immune signatures of HIV‐1 vaccines in human PBMCs
Author(s) -
Monaco Alessandro,
Marincola Francesco M.,
Sabatino Marianna,
Pos Zoltan,
Tornesello Maria Lina,
Stroncek David F.,
Wang Ena,
Lewis George K.,
Buonaguro Franco M.,
Buonaguro Luigi
Publication year - 2009
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/j.febslet.2009.07.060
Subject(s) - peripheral blood mononuclear cell , immune system , immunology , chemokine , viral load , vaccination , ex vivo , virology , hiv vaccine , biology , human immunodeficiency virus (hiv) , virus , aids vaccines , medicine , vaccine trial , in vivo , in vitro , biochemistry , microbiology and biotechnology
This ex vivo screening strategy represents an efficient tool for guiding modifications/optimizations of vaccination strategies and understanding failures in individuals enrolled in clinical trials.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom